(All figures are presented in U.S. Dollars)
Generated $8.3 million in cash during Q4 2024Natroba™ revenue was $12.0 million for the 5 months of fiscal 2024 since acquisitionFull year adjusted EBITDA1 of $15.7 million, an increase of 23% over fiscal 2023Cash at December 31, 2024 was $17.8 million or $0.70 per outstanding common shareEpuris revenue grew by 20% in fiscal 2024 compared to fiscal 2023Reactivation of a Normal Course Issuer Bid, which may include block purchases of the Company's common shares in accordance with TSX policiesThe information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.
RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.
Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.
On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.